A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema
Clinical trial NCT02316353 · COMPLETED
Trial details
- NCT number
- NCT02316353
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-31
- Primary completion
- 2017-09-21
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.